Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease-Reference-Cited by-同舟云学术

Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease

Published:2011-03-08 Issue:1 Volume:27 Page:15-21
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int. J. Geriat. Psychiatry

Author:

Ihl Ralf,Ferris Steven,Robert Philippe,Winblad Bengt,Gauthier Serge,Tennigkeit Frank

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gps.2679/fullpdf

Reference17 articles.

1. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomized, double-blind, placebo-controlled 6-month study;Bakchine;J Alzheimer's Dis,2008

2. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines;Ferris;Alzheimer Dis Assoc Disord,1997

3. Cognitive testing and drug development;Harrison;Clin Res Focus,2001

4. Measuring cognitive change in Alzheimer's disease clinical drug trials;Harrison;The JNHA,2007

5. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations;Hobart;Lancet Neurol,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repositioning of Pioglitazone in Management and Improving the Cognitive Function among the Patients with Mild to Moderate Alzheimer's Disease;Neurology India;2023-11

2. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer’s disease using bedside cognitive assessments;Journal of Clinical and Experimental Neuropsychology;2022-11-26

3. Test–retest reliabilities and minimal detectable changes of 5 versions of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale in people with dementia;Disability and Rehabilitation;2022-04-10

4. Cognitive impairment networks in Alzheimer's disease: Analysis of three double-blind randomized, placebo-controlled, clinical trials of donepezil;European Neuropsychopharmacology;2022-04

5. Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial;Neurophysiologie Clinique;2022-04